IgG-immunostaining in the intact rabbit brain: Variable but significant staining of hippocampal and cerebellar neurons with anti-IgG

Brain Research

Volumn 956, Issue 1, 2002, Pages 53-66

  Yoshimi, Kenji ^a,b   Woo, Monica ^a   Son, Yubei ^c   Baudry, Michel ^a   Thompson, Richard F ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b DAIICHI SANKYO CO   (Japan)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Cerebellum; Hippocampus; Immunoglobulin; Immunohistochemistry; Neuroimmunology; Non specific staining

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CD56 ANTIGEN; IMMUNOGLOBULIN G; NERVE CELL ADHESION MOLECULE;

ABSORPTION; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN NERVE CELL; CELL NUCLEUS; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; CROSS REACTION; DENDRITE; HIPPOCAMPUS; IMMUNOGLOBULIN PRODUCTION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; MALE; MESENCEPHALON; MICROGLIA; MOLECULE; NERVE FIBER; NONHUMAN; PERIKARYON; PRIORITY JOURNAL; PURKINJE CELL; RABBIT; RAT; THALAMUS;

ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; ASTROCYTES; BRAIN; BRAIN CHEMISTRY; CEREBELLUM; HIPPOCAMPUS; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MICE; MICROGLIA; NEURONS; RABBITS; RATS; RNA, MESSENGER; SPECIES SPECIFICITY;

EID: 0037159619     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)03479-0     Document Type: Article

References (49)

1. Albert M.L., Austin L.M., Darnell R.B. Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration. Ann. Neurol. 47:2000;9-17.
2. Archelos J.J., Hartung H.P. Pathogenetic role of autoantibodies in neurological diseases. Trends Neurosci. 23:2000;317-327.
3. Ariizumi M. Localization of immunoglobulins in the central nervous system. No-To-Hattatsu. 25:1993;107-113.
4. Bard F., Cannon C., Barbour R., Burke R.L., Games D., Grajeda H., Guido T., Hu K., Huang J., Johnson-Wood K., Khan K., Kholodenko D., Lee M., Lieberburg I., Motter R., Nguyen M., Soriano F., Vasquez N., Weiss K., Welch B., Seubert P., Schenk D., Yednock T. Peripherally-administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat. Med. 6:2000;916-919.
5. Brazil M.I., Chung H., Maxfield F.R. Effects of incorporation of immunoglobulin G and complement component C1q on uptake and degradation of Alzheimer's disease amyloid fibrils by microglia. J. Biol. Chem. 275:2000;16941-16947.
6. Correale J., Gilmore W., Lopez J., Li S.Q., McMillan M., Weiner L.P. Defective post-thymic tolerance mechanisms during the chronic progressive stage of multiple sclerosis. Nat. Med. 2:1996;1354-1360.
7. Correale J., Rojany M., Weiner L.P. Human CD8+ TCR-alpha beta(+) and TCR-gamma delta(+) cells modulate autologous autoreactive neuroantigen-specific CD4+ T-cells by different mechanisms. J. Neuroimmunol. 80:1997;47-64.
8. Crispino M., Stone D.J., Wei M., Anderson C.P., Tocco G., Finch C.E., Baudry M. Variations of synaptotagmin I, synaptotagmin IV, and synaptophysin mRNA levels in rat hippocampus during the estrous cycle. Exp. Neurol. 159:1999;574-583.
9. Czurko A., Nishino H. Appearance of immunoglobulin G and complement factor C3 in the striatum after transient focal ischemia in the rat. Neurosci. Lett. 166:1994;51-54.
10. Darnell R.B. Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain. Proc. Natl. Acad. Sci. USA. 93:1996;4529-4536.
11. Davis T.L., Wiley R.G. Anti-Thy-1 immunotoxin, OX7-saporin, destroys cerebellar Purkinje cells after intraventicular injection in rats. Brain Res. 504:1989;216-222.
12. Doherty P., Fazeli M.S., Walsh F.S. The neural cell adhesion molecule and synaptic plasticity. J. Neurobiol. 26:1995;437-446.
13. Dunn J.A., Kirsch J.D., Naegele J.R. Transient immunoglobulin-like molecules are present in the subplate zone and cerebral cortex during postnatal development. Cereb. Cortex. 5:1995;494-505.
14. Engelhardt J.I., Siklos L., Appel S.H. Altered calcium homeostasis and ultrastructure in motoneurons of mice caused by passively transferred anti-motoneuronal IgG. J. Neuropathol. Exp. Neurol. 56:1997;21-39.
15. Fabian R.H., Ritchie T.C. Intraneuronal IgG in the central nervous system. J. Neurol. Sci. 73:1986;257-267.
16. Fabian R.H., Petroff G. Intraneuronal IgG in the central nervous system: Uptake by retrograde axonal transport. Neurology. 37:1987;1780-1784.
17. Fairen A., Fernandez A.S., Marti E., DeDiego I., de la Rosa E.J. A transient immunoglobulin-like reactivity in the developing cerebral cortex of rodents. Neuroreport. 3:1992;881-884.
18. Friedman A., Kaufer D., Shemer J., Hendler I., Soreq H., Tur-Kaspa I. Pyridostigmine brain penetration under stress enhances neuronal excitability and induces early immediate transcriptional response. Nat. Med. 2:1996;1382-1385.
19. Gomi H., Sun W., Finch C.E., Itohara S., Yoshimi K., Thompson R.F. Learning induces a CDC2-related protein kinase, KKIAMRE. J. Neurosci. 19:1999;9530-9537.
20. Graus F., Illa I., Agusti M., Ribalta T., Cruz-Sanchez F., Jurarez C. Effect of intraventricular injection of an anti-Purkinje cell antibody (anti-Yo) in a guinea pig model. J. Neurol. Sci. 106:1991;82-87.
21. Graus F., Dalmau J., Valldeoriola F., Ferrer I., Rene R., Marin C., Vecht C.J., Arbizu T., Targa C., Moll J.W. Immunological characterization of a neuronal antibody (anti-Tr) associated with paraneoplastic cerebellar degeneration and Hodgkin's disease. J. Neuroimmunol. 74:1997;55-61.
22. Grundstrom E., Lindholm D., Johansson A., Blennow K., Askmark H. GDNF but not BDNF is increased in cerebrospinal fluid in amyotrophic lateral sclerosis. Neuroreport. 11:2000;1781-1783.
23. He X.P., Patel M., Whitney K.D., Janumpalli S., Tenner A., McNamara J.O. Glutamate receptor GluR3 antibodies and death of cortical cells. Neuron. 20:1998;153-163.
24. Hoshino S., Kobayashi S., Nakazawa S. Prolonged and extensive IgG immunoreactivity after severe fluid-percussion injury in rat brain. Brain Res. 711:1996;73-83.
25. Kim J.J., Thompson R.F. Cerebellar circuits and synaptic mechanisms involved in classical eyeblink conditioning. Trends Neurosci. 20:1997;177-181.
26. Lambin P., Gervais A., Levy M., Defendini E., Dubarry M., Lebon P., Rouger P., Schuller E. Intrathecal synthesis of IgG subclasses in multiple sclerosis and in acquired immunodeficiency syndrome (AIDS). J. Neuroimmunol. 35:1991;179-189.
27. Le W.D., Engelhardt J., Xie W.J., Schneider L., Smith R.G., Appel S.H. Experimental autoimmune nigral damage in guinea pigs. J. Neuroimmunol. 57:1995;45-53.
28. Matz P.G., Lewen A., Chan P.H. Neuronal, but not microglial, accumulation of extravasated serum proteins after intracerebral hemolysate exposure is accompanied by cytochrome c release and DNA fragmentation. J. Cereb. Blood Flow Metab. 21:2001;921-928.
29. McRae-Degueurce A., Gottfries C.G., Karlsson I., Svennerholm L., Dahlstrom A. Antibodies in the CSF of a Parkinson patient recognizes neurons in rat mesencephalic regions. Acta Physiol. Scand. 126:1986;313-315.
30. Ovadia H., Abramsky O., Feldman S., Weidenfeld J. Evaluation of the effect of stress on the blood brain barrier: critical role of the brain perfusion time. Brain Res. 905:2000;21-25.
31. Pullen A.H., Humphreys P. Ultrastructural analysis of spinal motoneurones from mice treated with IgG from ALS patients, healthy individuals, or disease controls. J. Neurol. Sci. 180:2000;35-45.
32. Schenk D., Barbour R., Dunn W., Gordon G., Grajeda H., Guido T., Hu K., Huang J., Johnson-Wood K., Khan K., Kholodenko D., Lee M., Liao Z., Lieberburg I., Motter R., Mutter L., Soriano F., Shopp G., Vasquez N., Vandevert C., Walker S., Wogulis M., Yednock T., Games D., Seubert P. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature. 400:1999;173-177.
33. Schmidt-Kastner R., Meller D., Bellander B.M., Stromberg I., Olson L., Ingver M. A one-step immunohistochemical method for detection of blood-brain barrier disturbances for immunoglobulins in lesioned rat brain with special reference to false-positive labeling in immunohistochemistry. J. Neurosci. Methods. 46:1993;121-132.
34. Sillevis-Smitt P., Kinoshita A., De Leeuw B., Moll W., Coesmans M., Jaarsma D., Henzen-Logmans S., Vecht C., De Zeeuw C., Sekiyama N., Nakanishi S., Shigemoto R. Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor. N. Engl. J. Med. 342:2000;21-27.
35. Silver R., Silverman A.J., Vitkovic L., Lederhendler I.I. Mast cells in the brain: evidence and functional significance. Trends Neurosci. 19:1996;25-31.
36. Silverman A.J., Sutherland A.K., Wilhelm M., Silver R. Mast cells migrate from blood to brain. J. Neurosci. 20:2000;401-408.
37. Sinton C.M., Fitch T.E., Petty F., Haley R.W. Stressful manipulations that elevate corticosterone reduce blood-brain barrier permeability to pyridostigmine in the rat. Toxicol. Appl. Pharmacol. 165:2000;99-105.
38. Sohma Y., Sasano H., Shiga R., Saeki S., Suzuki T., Nagura H., Nose M., Yamamoto T. Accumulation of plasma cells in atherosclerotic lesions of Watanabe heritable hyperlipidemic rabbits. Proc. Natl. Acad. Sci. USA. 92:1995;4937-4941.
39. Vedeler C., Ulvestad E., Grundt I., Conti G., Nyland H., Matre R., Pleasure D. Fc receptor for IgG (FcR) on rat microglia. J. Neuroimmunol. 49:1994;19-24.
40. Waite J.J., Chen A.D., Wardlow M.L., Wiley R.G., Lappi D.A., Thal L.J. 192 immunoglobulin G-saporin produces graded behavioral and biochemical changes accompanying the loss of cholinergic neurons of the basal forebrain and cerebellar Purkinje cells. Neuroscience. 65:1995;463-476.
41. Walsh T.J., Kelly R.M., Dougherty K.D., Stackman R.W., Wiley R.G., Kutscher C.L. Behavioral and neurobiological alterations induced by the immunotoxin 192-IgG-saporin: cholinergic and non-cholinergic effects following i.c.v. injection. Brain Res. 702:1995;233-245.
42. Webster S.D., Tenner A.J., Poulos T.L., Cribbs D.H. The mouse C1q A-chain sequence alters beta-amyloid-induced complement activation. Neurobiol. Aging. 20:1999;297-304.
43. Weiner J.A., Chun J. Maternally derived immunoglobulin light chain is present in the fetal mammalian CNS. J. Neurosci. 17:1997;3148-3156.
44. Whitney K.D., Andrews P.I., McNamara J.O. Immunoglobulin G and complement immunoreactivity in the cerebral cortex of patients with Rasmussen's encephalitis. Neurology. 53:1999;699-708.
45. Wurster U., Hass J. Passage of intravenous immunoglobulin and interaction with the CNS. J. Neurol. Neurosurg. Psychiatry. 57:(Suppl.):1994;21-25.
46. Yamamoto T., Iwasaki Y., Konno H., Iizawa H., Zhao J.X. Retrograde transport and differential accumulation of serum proteins in motor neurons: implications for motor neuron diseases. Neurology. 37:1987;843-846.
47. Yoshimi K., Iwata N., Takeda M., Nakamura Y., Nishimura T. Ischaemia-induced change in clathrin preceding delayed neuronal death. Neuroreport. 15:1995;453-456.
48. Yoshimi K., Takeda M., Nishimura T., Kudo T., Nakamura Y., Tada K., Iwata N. An immunohistochemical study of MAP2 and clathrin in gerbil hippocampus after cerebral ischemia. Brain Res. 560:1991;149-158.
49. Zhou J., Pliego-Rivero B., Bradford H.F., Stern G.M. The BDNF content of postnatal and adult rat brain: the effects of 6-hydroxydopamine lesions in adult brain. Brain Res. Dev. Brain Res. 97:1996;297-303.